Chakraborty, Souvik
Jiang, Chang
Gau, David
Oddo, Michael
Ding, Zhijie
Vollmer, Laura
Joy, Marion
Schiemann, William
Stolz, Donna Beer
Vogt, Andreas
Ghosh, Sujoy
Roy, Partha
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (2R01CA108607, P30CA047904)
Article History
Received: 21 December 2016
Revised: 31 August 2018
Accepted: 11 September 2018
First Online: 15 October 2018
Competing interests
: The authors declare no competing interests.
: Gene-specific survival outcomes in cancer patients were obtained through kmplot.com, a public domain data analysis tool that utilises curated genomic and clinical data available through Gene Expression Omnibus (GEO), European Genome-Phenome Archive (EGA) and The Cancer Gene Atlas (TCGA).
: No ethical approval and consent to participate were needed as the breast cancer TMA was purchased from Yale where the clinicopathological features of the cases were provided in a completely anonymous manner. The study was performed in accordance with the declaration of Helsinki.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0)